Nailfold capillaroscopy. Microscopic assessment of microcirculation abnormalities in systemic sclerosis;Kapilaroskopia wału paznokciowego. Mikroskopowa ocena zmian morfologicznych mikrokra̧żenia w twardzinie układowej

Postepy Dermatologii i Alergologii

Volumn 27, Issue 2, 2010, Pages 106-118

  Michalska Jakubus, Małgorzata ^a   Chodorowska, Grazyna ^a   Krasowska, Dorota ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Microangiopathy; Nailfold capillaroscopy; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

CAPILLAROSCOPY; CLINICAL PRACTICE; FUNCTIONAL ASSESSMENT; IN VIVO STUDY; MICROCIRCULATION; NAIL; PATHOGENESIS; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC SCLEROSIS;

EID: 77952479509     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Grassi W, Del Medico P (eds.). Atlas of capillaroscopy. EDRA - Medical Publishing & New Media, Milano 2004.
2. Hern S, Mortimer PS. Visualization of dermal blood vessels- capillaroscopy. Clin Exp Dermatol 1999; 24: 473-478
3. Jabłońska S, Chorzelski T. Budowa i czynności skóry. W: Choroby skóry. Jabłońska S, Chorzelski T (red.) Wydawnictwo PZWL, Warszawa 2005; 15-28.
4. Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol 2005; 19: 437-452
5. Fagrell B, Intaglietta M. Microcirculation: its significance in clinical and molecular medicine. J Intern Med 1997; 241: 349-362 (Pubitemid 27244659)
6. Shore AC. Capillaroscopy and the measurement of capillary pressure. Br J Clin Pharmacol 2000; 50: 501-513
7. Bollinger A, Butti P, Barras JP, et al. Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique. Microvasc Res 1974; 7: 61-72.
8. Fagrell B, Fronek A, Intaglietta M. Capillary flow components and reactive hyperemia in human skin capillaries studied by clinical television microscopy. Bibl Anat 1977; 16: 112-115
9. Fagrell B, Fronek A, Intaglietta M. Capillary blood flow velocity during rest and post-occlusive reactive hyperemia in skin areas of the toes and lower leg. Bibl Anat 1977; 16: 159-161
10. Bollinger A, Jäger K, Roten A, et al. Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold. Pflugers Arch 1979; 382: 137-143 (Pubitemid 10196271)
11. Mackiewicz U, Mackiewicz S, Konys J. Kapilaroskopia wału paznokciowego w chorobach tkanki ła̧cznej. Metodyka badań i fizjomorfologia naczyń włosowatych. Pol Tyg Lek 1973; 28: 455-458
12. Cutolo M, Sulli A, Secchi ME, et al. The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. Best Pract Res Clin Rheumatol 2007; 21: 1093-1108 (Pubitemid 350194040)
13. Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981; 24: 1159-1165
14. Grassi W, De Angelis R. Capillaroscopy: questions and answers. Clin Rheumatol 2007; 26: 2009-2016
15. Blockmans D, Beyens G, Verhaeghe R. Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 1996; 15: 148-153 (Pubitemid 26124297)
16. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003; 48: 3023-3030
17. Cutolo M, Pizzorni C, Tuccio M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004; 43: 719-726
18. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalites in connective tissue disease by "wide-field" microscopy. Arthritis Rheum 1973; 16: 619-628
19. Maricq HR, LeRoy EC, D'Angelo WA, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 183-189
20. Silver RM, Maricq HR. Childhood dermatomyositis: serial microvascular studies. Pediatrics 1989; 83: 278-283
21. Furtado RN, Pucinelli ML, Cristo VV, et al. Scleroderma-like nailfold capillaroscopic abnormalites are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients. Lupus 2002; 11: 35-41.
22. Sulli A, Pizzorni C, Cutolo M. Nailfold videocapillaroscopy abnormalites in patients with antiphospholipid antibodies. J Rheumatol 2000; 27: 1574-1576
23. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM. Microvascular abnormalites in Sjögren's syndrome: nailfold capillaroscopy. Rheumatology 1999; 38: 826-830
24. Fahrig C, Breitinger L, Heidrich H. Vital capillary microscopic findings in the nailfold of patients with diabetes mellitus. Vasa 2000; 29: 258-263
25. Howlader MH, Smith PD. Microangiopathy in chronic venous insufficiency: quantitative assessment by capillary microscopy. Eur J Vasc Endovasc Surg 2003; 26: 325-331
26. Ranft J, Heidrich H. Vital capillary-microscopic findings in normal subjects, patients with peripheral arterial occlusive disease (Fontaine II to IV) and patients with thrombangiitis obliterans. Vasa 1986; 15: 138-142
27. Bartosińska J, Chodorowska G, Da̧browska-Członka M, Bartosiński J. Zmiany kapilaroskopowe w łuszczycy. Nowa Medycyna 2006; 1: 28-30.
28. Kamińska-Winciorek GM, Brzezińska-Wcisło LA. Ocena mikrokra̧żenia za pomoca̧ konwencjonalnej kapilaroskopii u pacjentek z tra̧dzikiem różowatym - doniesienie wstȩpne. Wiad Lek 2006; 59: 618-622
29. Cutolo M, Pizzorni C, Sulli A. Nailfold video-capillaroscopy in systemic sclerosis. Z Rheumatol 2004; 63: 457-462
30. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986; 13: 556-563 (Pubitemid 16058070)
31. Secchi ME, Sulli A, Grollero M, et al. Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud's phenomenon in systemic sclerosis. Reumatismo 2008; 60: 102-107
32. Gińdzieńska-Sieśkiewicz E, Klimiuk PA, Kowal-Bielecka O, Sierakowski S. Aspekty immuno-patologiczne twardziny układowej. Pol Merkuriusz Lek 2005; 19: 800-803
33. Sierakowski S, Sierakowska M. Twardzina układowa. W: Choroby wewnȩtrzne. Szczeklik A (red.). Medycyna Praktyczna Kraków 2006; 1669-1676
34. Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity 2005; 38: 113-116 (Pubitemid 40872734)
35. Tamby MC, Chanseauda Y, Guillevinb L, Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimm Rev 2003; 2: 152-157 (Pubitemid 37443852)
36. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975; 4: 351-368
37. Distler JH, Kalden JR, Gray S, Distler O. Vascular changes in the pathogenesis of systemic sclerosis. Z Rheumatol 2004; 63: 446-450 (Pubitemid 40137273)
38. Kahaleh MB, LeRoy EC. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 1999; 31: 195-214. (Pubitemid 30179202)
39. Kahaleh MB. Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions. Rheum Dis Clin North Am 1990; 16: 53-73.
40. Kahaleh MB. Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004; 22 Suppl 33: S19-23.
41. Fleischmajer R, Perlish JS. Capillary alterations in scleroderma. J Am Acad Dermatol 1980; 2: 161-170
42. Herron GS, Romero LI. Vascular abnormalities in scleroderma. Semin Cutan Med Surg 1998; 17: 12-17
43. Freemont AJ, Hoyland J, Fielding P, et al. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy. Br J Dermatol 1992; 126: 561-588
44. Livi R, Teghini L, Generini S, Matucci Cerinic M. The loss of endothelium dependent vascular tone control in systemic sclerosis. Chest 2001; 119: 672-673 (Pubitemid 32163803)
45. Kahaleh MB. Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 2004; 16: 718-722
46. Fleming JN, Schwartz SM. The pathology of scleroderma vascular disease. Rheum Dis Clin North Am 2008; 34: 41-55.
47. Prescott RJ, Freemont AJ, Jones CJ, et al. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166: 255-263
48. Ames PR, Lupoli S, Alves J, et al. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol 1997; 36: 1045-1050
49. Cafagna D, Melon F, Balbi M, Ponte E. Vascular manifestations in systemic sclerosis (scleroderma). Minerva Med 1998; 89: 153-161 (Pubitemid 28337801)
50. Denton CP, Korn JH. Digital ulceration and critical digital ischemia in scleroderma. Scleroderma Care Res 2003; 1: 12-16
51. Distler JH, Gay S, Distler O. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology (Oxford) 2006; 45 (Suppl 3): iii 26-27
52. Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 2007; 9 (Suppl 2): S3.
53. Mulligan-Kehoe MJ, Simons M. Vascular disease in scleroderma: angiogenesis and vascular repair. Rheum Dis Clin North Am 2008; 34: 73-79 (Pubitemid 351337629)
54. Konttinen YT, Mackiewicz Z, Ruuttila P, et al. Vascular damage and lack of angiogenesis in systemic sclerosis skin. Clin Rheumatol 2003; 22: 196-202.
55. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-160
56. Jabłońska S, Bubnow B, Łukasiak B. Raynaud's syndrome: acrosclerosis, scleroderma. Br J Dermatol 1958; 70: 37-43.
57. Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990; 16: 75-91.
58. Jafiszow U, Kowal-Bielecka O, Sierakowski S. Kapilaroskopia w diagnostyce twardziny układowej. Post Hig Med Dosw 2005; 59: 340-345
59. Maricq HR, Harper FE, Khan MM, et al. Microvascular abnormalities as possible predictors of disease onset in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195-205.
60. Wong ML, Highton J, Palmer DG. Sequential naifold capillary microscopy in scleroderma and related disorders. Ann Rheum Dis 1988; 47: 53-61.
61. ter Borg EJ, Piersma-Wichers G, Smit AJ, et al. Serial naifold capillary microscopy in primary Raynaud's phenomenon and scleroderma. Semin Arthritis Rheum 1994; 24: 40-47
62. Cutolo M, Matucci Cerinic M. Nailfold capillaroscopy and classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007; 25: 663-665
63. Lonzetti LS, Joyal F, Raynaud JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalites markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-736
64. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-1576
65. Chen ZY, Silver RM, Ainsworth SK, et al. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984; 77: 812-822
66. Bredemeier M, Xavier RM, Capobianco KG, et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31: 286-294
67. Silver RM, Metcalf JF, Stanley JH, LeRoy EC. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum 1984; 27: 1254-1262
68. Schmidt KU, Mensing H. Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 1988; 176: 18-21.
69. Kabasakal Y, Elvins DM, Ring EF, et al. Quantitative capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55: 507-512
70. Filaci C, Cutolo M, Scudeletti M, et al. Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 1999; 38: 992-996
71. Faggioli P, Giani L, Mazzone A. Possible role of iloprost (stable analogue of PGI2) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 2006; 24: 220.
72. Masłowski L. Choroby mikrokra̧żenia. W: Choroby wewnȩtrzne. Szczeklik A (red.). Medycyna Praktyczna, Kraków 2006; 425-429
73. Bolster MB, Maricq HR, Leff RL. Office evaluation and treatment of Raynaud's phenomenon. Cleve Clin J Med 1995; 62: 51-61.
74. LeRoy EC, Medsger TA Jr. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10: 485-488
75. Spencer-Green G. Outcomes in primary Raynaud's phenomenon. A meta-analysis of frequency, rates and predictors of transition to secondary disease. Arch Intern Med 1998; 158: 595-600.
76. Luggen M, Belhorn L, Evans T, et al. The evolution of Raynaud's phenomenon: a long term prospective study. J Rheumatol 1995; 22: 2226-2232
77. Zuffery P, Depairon M, Chamot AM, et al. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities: a six-year follow-up study. Clin Rheumatol 1992; 11: 536-541